SkyView Investment Advisors’s Biogen BIIB Stock Holding History

SkyView Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,859	Closed	-$530K	–	611
2023 Q2	$530K	Sell	1,859 -1,585	-46%	-$472K	0.13%	205
2023 Q1	$958K	Sell	3,444 -42	-1%	-$11.6K	0.22%	119
2022 Q4	$965K	Sell	3,486 -203	-6%	-$57.3K	0.29%	114
2022 Q3	$985K	Sell	3,689 -176	-5%	-$37.4K	0.29%	112
2022 Q2	$788K	Sell	3,865 -1,205	-24%	-$246K	0.21%	159
2022 Q1	$1.03M	Sell	5,070 -32,799	-87%	-$7.13M	0.24%	121
2021 Q4	$1.15M	Buy	37,869 +33,975	+872%	+$8.74M	0.26%	94
2021 Q3	$1.1M	Buy	3,894 +2,344	+151%	+$768K	0.31%	81
2021 Q2	$434K	Hold	1,550	–	–	0.2%	105
2021 Q1	$434K	Buy	1,550 +244	+19%	+$65.8K	0.19%	110
2020 Q4	$320K	Buy	+1,306	New	+$337K	0.15%	140

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SkyView Investment Advisors's BIIB Position: Q3 2023 in Review

SkyView Investment Advisors sold out of Biogen (BIIB) in Q3 2023, closing a stake of 1,859 shares — an estimated $530K sold.

SkyView Investment Advisors first reported a position in BIIB in Q4 2020 and held it in 11 quarters. The position peaked at $1.15M in Q4 2021. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

SkyView Investment Advisors reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
SkyView Investment Advisors sold 1,859 Biogen shares in Q3 2023, an estimated $530K.
SkyView Investment Advisors first reported a position in Biogen in Q4 2020 and held it in 11 quarters.
SkyView Investment Advisors's Biogen position peaked at $1.15M in Q4 2021.
965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on SkyView Investment Advisors's 13F filing for Q3 2023, filed 17 Nov 2023.